Device Endo-Mechanical

Echelon Circular

Payments companies reported to CMS as associated with Echelon Circular. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$724Kassociated payments (2023-2025)

1,826clinicians with associated payments

5companies reporting

By year

2023 $183K

2024 $222K

2025 $319K

Payments reported as associated with Echelon Circular, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Colon & Rectal Surgery $294K

Surgery $262K

Thoracic Surgery (Cardiothoracic Vascular Surgery) $77K

Orthopaedic Trauma $15K

Adult Reconstructive Orthopaedic Surgery $12K

Physician Assistant $5,498

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Echelon Circular

These are the largest totals companies reported as associated with Echelon Circular. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Christopher Ducoin	Tampa, FL	Surgery	$99,631.86
Diego Marines Copado	Houston, TX	Colon & Rectal Surgery	$65,129.91
Isaac Felemovicius	Maple Grove, MN	Colon & Rectal Surgery	$64,043.19
David Longcope	Denver, CO	Colon & Rectal Surgery	$59,703.30
Jean Ashburn	Cleveland, OH	Colon & Rectal Surgery	$42,151.93
Olugbenga Okusanya	Philadelphia, PA	Thoracic Surgery (Cardiothoracic Vascular Surgery)	$37,085.78
Thomas Sonnanstine	Columbus, OH	Surgery	$27,972.93
Brian Binetti	Rhinebeck, NY	Surgery	$26,408.84
Kelvin Higa	Fresno, CA	Surgery	$18,900.00
George Crawford	Anniston, AL		$18,444.94

Prescribed Echelon Circular?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.